Inhibition of MICA and MICB shedding enhances memory-like NK-cell-mediated cytotoxicity against multiple myeloma

Affiliations

• ¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
• ² Department of Medical Oncology, Harvard Medical School, Boston, MA.
• ³ Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.
• ⁴ Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.
• ⁵ Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
• ⁶ Medical Department, Christian-Albrechts University, Kiel, Germany.
• ⁷ Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA.
• ⁸ Precision Immunology Institute, Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai Hospital, New York, NY.
• ⁹ Cancer Science Institute of Singapore, National University of Singapore Cancer Science, Singapore, Singapore.
• ¹⁰ Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
• ¹¹ Clínica Universidad de Navarra, Center for Applied Medical Research, CIBERONC, IDISNA, Pamplona, Spain.
• ¹² Krantz Family Center for Cancer Research and Deptartment of Pathology, Massachusetts General Hospital, Boston, MA.
• ¹³ Department of Pathology, Harvard Medical School, Boston, MA.
• ¹⁴ Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.